CD19 and Parkinson disease: By detecting the number of T cells, B cells, NK cells, and monocytes in peripheral blood, it was found that CD4+ T and CD19+ B cells decreased slightly (15-25%) in patients with PD [13], and the decrease of CD3+, CD4+, CD8+ T, and B cell was associated with the progression of PD [14].